Mr. Kerner has played a major role in some of the most hotly-contested and high-profile mass torts and MDLs in the past 25 years. In the area of pharmaceuticals, Mr. Kerner has served as national counsel in mass torts and MDLs involving metoclopramide, pamidronate, propofol, PPA, the diet drug fen-phen and alendronate, where he was appointed as liaison counsel for the generic pharmaceutical defendants. He currently serves as national counsel for a large generic pharmaceutical company in nearly 400 amiodarone cases in a JCCP in Northern California, and throughout the country. Other mass torts and MDLs in which Mr. Kerner has been actively involved include semiconductor clean rooms, ceramic hip devices, ephedra, natural rubber latex gloves and orthopedic bone screws. He has successfully litigated individual cases concerning various consumer products, as well as pharmaceuticals and orthopedic medical devices. Mr. Kerner has acted as lead trial counsel in cases across multiple industries and jurisdictions. In his role as national counsel, Mr. Kerner supervises local counsel and is responsible for coordinating and maintaining a consistent litigation strategy on a nationwide basis. He works closely with a national network of medical, scientific, regulatory and industry experts in preparation for trials and Daubert hearings.
Mr. Kerner also routinely provides strategic counseling to clients on litigation avoidance and risk management in various industries. He advises clients on labeling and warnings issues, including regulatory compliance.
Mr. Kerner is a member of Goodwin’s Nanotechnology and Cannabis practices. He is also the immediate past Chair of the Food Law Special Litigation Group of the Defense Research Institute’s (DRI) Products Liability Committee and a past Chair of its Class Action and Mass Tort SLG. He also serves on the Steering Committee for DRI’s Drug and Medical Device Committee.